Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 5, 2026 23:00 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,171 | $25.68 | $55,751.28 |
DisclosureSEC source: 0001551306-26-000006 · wk-form4_1767654010.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,462 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| November 10, 2025 Filed Nov 14, 2025 00:49 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 21,286 | $22.37 | $476,167.82 |
DisclosureSEC source: 0001551306-25-000195 · wk-form4_1763081359.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,633 F2 · shares: Shares withheld for payment of withholding taxes upon the vesting of the PSUs granted to the Reporting Person. Read SEC document |
| November 10, 2025 Filed Nov 14, 2025 00:49 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 41,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-25-000195 · wk-form4_1763081359.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,919 F1 · shares: Represents performance stock units ("PSUs") that were earned pursuant to the terms of a PSU award granted on January 1, 2022 (the "Award"). Each PSU vested on October 31, 2025, which is the date the Compensation Committee certified the achievement of the applicable performance conditions in accordance with the Award. Pursuant to terms of the Award, each PSU entitled the Reporting Person to receive one share of common stock for each PSU. The vested shares were settled on November 10, 2025 after the Issuer's trading blackout period ended and trading was permitted to commence. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:26 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 1,893 | $21.52 | $40,737.36 |
DisclosureSEC source: 0001576145-25-000003 · wk-form4_1759436807.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,419 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 1,893 | $22.00 | $41,646.00 |
DisclosureSEC source: 0001551306-25-000150 · wk-form4_1751487038.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,312 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:14 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 1,893 | $22.34 | $42,289.62 |
DisclosureSEC source: 0001551306-25-000059 · wk-form4_1743711262.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,205 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,171 | $17.25 | $37,449.75 |
DisclosureSEC source: 0001551306-25-000004 · wk-form4_1736200514.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,098 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| December 26, 2024 Filed Dec 26, 2024 22:35 UTC | Progyny, Inc. PGNY · Entity 4521 | PurchaseCommon Stock | 150,000 | $14.68 | $2,202,330.00 |
DisclosureSEC source: 0001551306-24-000217 · wk-form4_1735252496.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,269 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.60 to $14.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 12:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,681 | $16.76 | $44,933.56 |
DisclosureSEC source: 0001551306-24-000187 · wk-form4_1727959181.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,269 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:54 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,681 | $28.61 | $76,703.41 |
DisclosureSEC source: 0001551306-24-000142 · wk-form4_1719953686.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,950 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000059 · wk-form4_1712179613.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,309,022 Underlying: Common Stock · 1,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:27 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,000 | $37.52 | $37,522.50 |
DisclosureSEC source: 0001551306-24-000059 · wk-form4_1712179613.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,631 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,681 | $38.15 | $102,280.15 |
DisclosureSEC source: 0001551306-24-000059 · wk-form4_1712179613.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,631 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,000 | $3.95 | $3,950.00 |
DisclosureSEC source: 0001551306-24-000059 · wk-form4_1712179613.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 23:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 71,272 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000051 · wk-form4_1711753284.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,310,022 Underlying: Common Stock · 71,272 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 23:01 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 71,272 | $37.80 | $2,694,266.91 |
DisclosureSEC source: 0001551306-24-000051 · wk-form4_1711753284.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 23:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 71,272 | $3.95 | $281,845.12 |
DisclosureSEC source: 0001551306-24-000051 · wk-form4_1711753284.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:49 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 305 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000049 · wk-form4_1711576136.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,381,294 Underlying: Common Stock · 305 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 305 | $37.50 | $11,438.54 |
DisclosureSEC source: 0001551306-24-000049 · wk-form4_1711576136.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:49 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 305 | $3.95 | $1,206.12 |
DisclosureSEC source: 0001551306-24-000049 · wk-form4_1711576136.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:49 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,597 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000049 · wk-form4_1711576136.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,381,599 Underlying: Common Stock · 2,597 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:49 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,597 | $37.65 | $97,778.09 |
DisclosureSEC source: 0001551306-24-000049 · wk-form4_1711576136.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.55 to $37.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:49 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 2,597 | $3.95 | $10,269.84 |
DisclosureSEC source: 0001551306-24-000049 · wk-form4_1711576136.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,826 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000047 · wk-form4_1711406531.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,384,196 Underlying: Common Stock · 5,826 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,826 | $37.74 | $219,876.74 |
DisclosureSEC source: 0001551306-24-000047 · wk-form4_1711406531.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.74 to $37.755, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 5,826 | $3.95 | $23,038.92 |
DisclosureSEC source: 0001551306-24-000047 · wk-form4_1711406531.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 23:38 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000011 · wk-form4_1707349088.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,390,022 Underlying: Common Stock · 20,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 23:38 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,862 | $38.86 | $227,786.18 |
DisclosureSEC source: 0001551306-24-000011 · wk-form4_1707349088.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.82 to $38.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 23:38 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 14,138 | $38.35 | $542,141.40 |
DisclosureSEC source: 0001551306-24-000011 · wk-form4_1707349088.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,174 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.82 to $38.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 23:38 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 20,000 | $3.95 | $79,090.00 |
DisclosureSEC source: 0001551306-24-000011 · wk-form4_1707349088.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,410,022 Underlying: Common Stock · 30,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 13,259 | $39.24 | $520,283.16 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.06 to $39.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 16,741 | $38.66 | $647,207.06 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,571 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $39.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 30,000 | $3.95 | $118,635.00 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,440,022 Underlying: Common Stock · 30,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,258 | $38.69 | $474,262.02 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.595 to $38.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 17,742 | $38.01 | $674,373.42 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,570 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.60 to $38.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 23:51 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 30,000 | $3.95 | $118,635.00 |
DisclosureSEC source: 0001551306-24-000007 · wk-form4_1707177090.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:31 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 66,002 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000006 · wk-form4_1704929454.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,470,022 Underlying: Common Stock · 66,002 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:31 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 66,002 | $37.88 | $2,500,155.76 |
DisclosureSEC source: 0001551306-24-000006 · wk-form4_1704929454.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:31 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 66,002 | $3.95 | $261,004.91 |
DisclosureSEC source: 0001551306-24-000006 · wk-form4_1704929454.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,998 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-24-000002 · wk-form4_1704411024.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,536,024 Underlying: Common Stock · 13,998 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,127 | $37.18 | $79,081.86 |
DisclosureSEC source: 0001551306-24-000002 · wk-form4_1704411024.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,312 F3 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 13,998 | $37.58 | $526,023.84 |
DisclosureSEC source: 0001551306-24-000002 · wk-form4_1704411024.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 13,998 | $3.95 | $55,355.09 |
DisclosureSEC source: 0001551306-24-000002 · wk-form4_1704411024.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 01:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 76,031 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-23-000118 · wk-form4_1703812740.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,550,022 Underlying: Common Stock · 76,031 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 01:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 76,031 | $37.66 | $2,863,525.14 |
DisclosureSEC source: 0001551306-23-000118 · wk-form4_1703812740.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to 37.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 01:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 76,031 | $3.95 | $300,664.59 |
DisclosureSEC source: 0001551306-23-000118 · wk-form4_1703812740.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2023 Filed Dec 29, 2023 01:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-23-000118 · wk-form4_1703812740.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,626,053 Underlying: Common Stock · 80,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 26, 2023 Filed Dec 29, 2023 01:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 80,000 | $37.93 | $3,034,760.00 |
DisclosureSEC source: 0001551306-23-000118 · wk-form4_1703812740.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.52 to $38.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.